JPWO2022266396A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022266396A5 JPWO2022266396A5 JP2023577531A JP2023577531A JPWO2022266396A5 JP WO2022266396 A5 JPWO2022266396 A5 JP WO2022266396A5 JP 2023577531 A JP2023577531 A JP 2023577531A JP 2023577531 A JP2023577531 A JP 2023577531A JP WO2022266396 A5 JPWO2022266396 A5 JP WO2022266396A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- seq
- protease
- optionally
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000035195 Peptidases Human genes 0.000 description 66
- 108091005804 Peptidases Proteins 0.000 description 66
- 239000004365 Protease Substances 0.000 description 66
- 150000001413 amino acids Chemical group 0.000 description 64
- 108090000765 processed proteins & peptides Proteins 0.000 description 57
- 238000003776 cleavage reaction Methods 0.000 description 51
- 230000007017 scission Effects 0.000 description 51
- 229920001184 polypeptide Polymers 0.000 description 47
- 102000004196 processed proteins & peptides Human genes 0.000 description 47
- 230000004913 activation Effects 0.000 description 37
- 230000004068 intracellular signaling Effects 0.000 description 37
- 210000000170 cell membrane Anatomy 0.000 description 34
- 239000012636 effector Substances 0.000 description 30
- 102000040430 polynucleotide Human genes 0.000 description 30
- 108091033319 polynucleotide Proteins 0.000 description 30
- 239000002157 polynucleotide Substances 0.000 description 30
- 210000004027 cell Anatomy 0.000 description 28
- 238000004873 anchoring Methods 0.000 description 27
- 238000013518 transcription Methods 0.000 description 26
- 230000035897 transcription Effects 0.000 description 26
- 102000037865 fusion proteins Human genes 0.000 description 25
- 108020001507 fusion proteins Proteins 0.000 description 25
- 230000027455 binding Effects 0.000 description 24
- 150000007523 nucleic acids Chemical class 0.000 description 22
- 102000039446 nucleic acids Human genes 0.000 description 20
- 108020004707 nucleic acids Proteins 0.000 description 20
- 239000012190 activator Substances 0.000 description 18
- 230000003248 secreting effect Effects 0.000 description 17
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 108091023040 Transcription factor Proteins 0.000 description 11
- 102000040945 Transcription factor Human genes 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 102000004127 Cytokines Human genes 0.000 description 10
- 108090000695 Cytokines Proteins 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 10
- 108010076504 Protein Sorting Signals Proteins 0.000 description 10
- 239000002773 nucleotide Substances 0.000 description 10
- 125000003729 nucleotide group Chemical group 0.000 description 10
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 9
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 9
- 102100024810 DNA (cytosine-5)-methyltransferase 3B Human genes 0.000 description 8
- 101710123222 DNA (cytosine-5)-methyltransferase 3B Proteins 0.000 description 8
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 8
- 108090000246 Histone acetyltransferases Proteins 0.000 description 8
- 102000003893 Histone acetyltransferases Human genes 0.000 description 8
- -1 ICOS Proteins 0.000 description 8
- 101710149136 Protein Vpr Proteins 0.000 description 8
- 101710122931 Replication and transcription activator Proteins 0.000 description 8
- 102100035100 Transcription factor p65 Human genes 0.000 description 8
- 230000004568 DNA-binding Effects 0.000 description 7
- 101000941994 Homo sapiens Protein cereblon Proteins 0.000 description 7
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 7
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 7
- 210000004899 c-terminal region Anatomy 0.000 description 7
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000003834 intracellular effect Effects 0.000 description 6
- 108091007505 ADAM17 Proteins 0.000 description 5
- 102100032530 Glypican-3 Human genes 0.000 description 5
- 101001014668 Homo sapiens Glypican-3 Proteins 0.000 description 5
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 description 5
- 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 description 5
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 description 5
- 102100032783 Protein cereblon Human genes 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000004481 post-translational protein modification Effects 0.000 description 5
- 108700014420 Chromobox Protein Homolog 5 Proteins 0.000 description 4
- 102100032918 Chromobox protein homolog 5 Human genes 0.000 description 4
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical group NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 4
- 101710155878 Histone acetyltransferase p300 Proteins 0.000 description 4
- 102100038885 Histone acetyltransferase p300 Human genes 0.000 description 4
- 101000882390 Homo sapiens Histone acetyltransferase p300 Proteins 0.000 description 4
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 4
- 102000003812 Interleukin-15 Human genes 0.000 description 4
- 108090000172 Interleukin-15 Proteins 0.000 description 4
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 description 4
- 206010034016 Paronychia Diseases 0.000 description 4
- 108010034634 Repressor Proteins Proteins 0.000 description 4
- 102000009661 Repressor Proteins Human genes 0.000 description 4
- 241000700584 Simplexvirus Species 0.000 description 4
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 4
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 4
- 208000008383 Wilms tumor Diseases 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 230000000735 allogeneic effect Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 230000030279 gene silencing Effects 0.000 description 4
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 4
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 108020001580 protein domains Proteins 0.000 description 4
- 210000003705 ribosome Anatomy 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 241000963438 Gaussia <copepod> Species 0.000 description 3
- 241000711549 Hepacivirus C Species 0.000 description 3
- 101000599042 Homo sapiens Zinc finger protein Aiolos Proteins 0.000 description 3
- 108010065805 Interleukin-12 Proteins 0.000 description 3
- 102000013462 Interleukin-12 Human genes 0.000 description 3
- 102100030704 Interleukin-21 Human genes 0.000 description 3
- 108060001084 Luciferase Proteins 0.000 description 3
- 239000005089 Luciferase Substances 0.000 description 3
- 101710144111 Non-structural protein 3 Proteins 0.000 description 3
- 102000003946 Prolactin Human genes 0.000 description 3
- 108010057464 Prolactin Proteins 0.000 description 3
- 101800001838 Serine protease/helicase NS3 Proteins 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 3
- 108010071390 Serum Albumin Proteins 0.000 description 3
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 3
- 102000044159 Ubiquitin Human genes 0.000 description 3
- 108090000848 Ubiquitin Proteins 0.000 description 3
- 102100037798 Zinc finger protein Aiolos Human genes 0.000 description 3
- 210000000172 cytosol Anatomy 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 108010074108 interleukin-21 Proteins 0.000 description 3
- 230000002601 intratumoral effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229940097325 prolactin Drugs 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 238000007910 systemic administration Methods 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 108091007504 ADAM10 Proteins 0.000 description 2
- 108091007507 ADAM12 Proteins 0.000 description 2
- 102100030009 Azurocidin Human genes 0.000 description 2
- 101710154607 Azurocidin Proteins 0.000 description 2
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 description 2
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
- 102100038077 CD226 antigen Human genes 0.000 description 2
- 108010021064 CTLA-4 Antigen Proteins 0.000 description 2
- 229940045513 CTLA4 antagonist Drugs 0.000 description 2
- 108010014419 Chemokine CXCL1 Proteins 0.000 description 2
- 102000016950 Chemokine CXCL1 Human genes 0.000 description 2
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 2
- 102100021069 E3 ubiquitin-protein ligase ZFP91 Human genes 0.000 description 2
- 102100035233 Furin Human genes 0.000 description 2
- 108090001126 Furin Proteins 0.000 description 2
- 102100029360 Hematopoietic cell signal transducer Human genes 0.000 description 2
- 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 description 2
- 101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 description 2
- 101000894883 Homo sapiens Beta-secretase 2 Proteins 0.000 description 2
- 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 description 2
- 101000884298 Homo sapiens CD226 antigen Proteins 0.000 description 2
- 101000777455 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 15 Proteins 0.000 description 2
- 101000777464 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 19 Proteins 0.000 description 2
- 101000689653 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 20 Proteins 0.000 description 2
- 101000689659 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 21 Proteins 0.000 description 2
- 101000756756 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 28 Proteins 0.000 description 2
- 101000720046 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 30 Proteins 0.000 description 2
- 101000720049 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 33 Proteins 0.000 description 2
- 101000832767 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 8 Proteins 0.000 description 2
- 101000832769 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 9 Proteins 0.000 description 2
- 101000818429 Homo sapiens E3 ubiquitin-protein ligase ZFP91 Proteins 0.000 description 2
- 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 description 2
- 101000945340 Homo sapiens Killer cell immunoglobulin-like receptor 2DS1 Proteins 0.000 description 2
- 101000945492 Homo sapiens Killer cell immunoglobulin-like receptor 3DS1 Proteins 0.000 description 2
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 2
- 101000645296 Homo sapiens Metalloproteinase inhibitor 2 Proteins 0.000 description 2
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 2
- 101000589305 Homo sapiens Natural cytotoxicity triggering receptor 2 Proteins 0.000 description 2
- 101001098872 Homo sapiens Proprotein convertase subtilisin/kexin type 7 Proteins 0.000 description 2
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 2
- 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 108090001007 Interleukin-8 Proteins 0.000 description 2
- 102000004890 Interleukin-8 Human genes 0.000 description 2
- 102100033631 Killer cell immunoglobulin-like receptor 2DS1 Human genes 0.000 description 2
- 102100034833 Killer cell immunoglobulin-like receptor 3DS1 Human genes 0.000 description 2
- 102000017578 LAG3 Human genes 0.000 description 2
- 101150030213 Lag3 gene Proteins 0.000 description 2
- 102100029193 Low affinity immunoglobulin gamma Fc region receptor III-A Human genes 0.000 description 2
- 108010091175 Matriptase Proteins 0.000 description 2
- 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 description 2
- 102000004044 Matrix metalloproteinase-16 Human genes 0.000 description 2
- 108090000561 Matrix metalloproteinase-16 Proteins 0.000 description 2
- 102100024129 Matrix metalloproteinase-24 Human genes 0.000 description 2
- 108050005214 Matrix metalloproteinase-24 Proteins 0.000 description 2
- 102100025169 Max-binding protein MNT Human genes 0.000 description 2
- 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 description 2
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 2
- 108010004217 Natural Cytotoxicity Triggering Receptor 1 Proteins 0.000 description 2
- 102100032870 Natural cytotoxicity triggering receptor 1 Human genes 0.000 description 2
- 102100032851 Natural cytotoxicity triggering receptor 2 Human genes 0.000 description 2
- 101800001019 Non-structural protein 4B Proteins 0.000 description 2
- 101800001014 Non-structural protein 5A Proteins 0.000 description 2
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 2
- 102100021079 Ornithine decarboxylase Human genes 0.000 description 2
- 108010077077 Osteonectin Proteins 0.000 description 2
- 108010035042 Osteoprotegerin Proteins 0.000 description 2
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 2
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 2
- 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 description 2
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 2
- 102100040678 Programmed cell death protein 1 Human genes 0.000 description 2
- 101710089372 Programmed cell death protein 1 Proteins 0.000 description 2
- 102100037599 SPARC Human genes 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000713880 Spleen focus-forming virus Species 0.000 description 2
- 101000915480 Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) Zinc metalloprotease ZmpC Proteins 0.000 description 2
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 2
- 102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 description 2
- 102100032236 Tumor necrosis factor receptor superfamily member 11B Human genes 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 208000006359 hepatoblastoma Diseases 0.000 description 2
- 229940124622 immune-modulator drug Drugs 0.000 description 2
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 2
- 208000022013 kidney Wilms tumor Diseases 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 201000005243 lung squamous cell carcinoma Diseases 0.000 description 2
- 108010047374 matriptase 2 Proteins 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 201000008026 nephroblastoma Diseases 0.000 description 2
- XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 201000003707 ovarian clear cell carcinoma Diseases 0.000 description 2
- 239000003375 plant hormone Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 108091006107 transcriptional repressors Proteins 0.000 description 2
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 description 2
- 102100026423 Adhesion G protein-coupled receptor E5 Human genes 0.000 description 1
- 108010031677 Anaphase-Promoting Complex-Cyclosome Proteins 0.000 description 1
- 102000005446 Anaphase-Promoting Complex-Cyclosome Human genes 0.000 description 1
- 102100027207 CD27 antigen Human genes 0.000 description 1
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 1
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 1
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- 102100037799 DNA-binding protein Ikaros Human genes 0.000 description 1
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 description 1
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 description 1
- 102100038595 Estrogen receptor Human genes 0.000 description 1
- 102100036816 Eukaryotic peptide chain release factor GTP-binding subunit ERF3A Human genes 0.000 description 1
- 102100034826 Homeobox protein Meis2 Human genes 0.000 description 1
- 101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 description 1
- 101000924727 Homo sapiens Alternative prion protein Proteins 0.000 description 1
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
- 101000599038 Homo sapiens DNA-binding protein Ikaros Proteins 0.000 description 1
- 101000898310 Homo sapiens Enhancer of filamentation 1 Proteins 0.000 description 1
- 101000851788 Homo sapiens Eukaryotic peptide chain release factor GTP-binding subunit ERF3A Proteins 0.000 description 1
- 101001069973 Homo sapiens Glutathione synthetase Proteins 0.000 description 1
- 101001019057 Homo sapiens Homeobox protein Meis2 Proteins 0.000 description 1
- 101001045824 Homo sapiens Kelch-like protein 3 Proteins 0.000 description 1
- 101000573901 Homo sapiens Major prion protein Proteins 0.000 description 1
- 101000961071 Homo sapiens NF-kappa-B inhibitor alpha Proteins 0.000 description 1
- 101000642268 Homo sapiens Speckle-type POZ protein Proteins 0.000 description 1
- 101000879604 Homo sapiens Transcription factor E4F1 Proteins 0.000 description 1
- 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 1
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 101900330356 Influenza A virus Matrix protein 2 Proteins 0.000 description 1
- 102000003810 Interleukin-18 Human genes 0.000 description 1
- 108090000171 Interleukin-18 Proteins 0.000 description 1
- 108090000484 Kelch-Like ECH-Associated Protein 1 Proteins 0.000 description 1
- 102000004034 Kelch-Like ECH-Associated Protein 1 Human genes 0.000 description 1
- 102100023684 Kelch-like protein 17 Human genes 0.000 description 1
- 101710173261 Kelch-like protein 17 Proteins 0.000 description 1
- 102100022101 Kelch-like protein 3 Human genes 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102100025818 Major prion protein Human genes 0.000 description 1
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
- 108700027649 Mitogen-Activated Protein Kinase 3 Proteins 0.000 description 1
- 102100024192 Mitogen-activated protein kinase 3 Human genes 0.000 description 1
- 101001041236 Mus musculus Ornithine decarboxylase Proteins 0.000 description 1
- 108010077432 Myeloid Differentiation Factor 88 Proteins 0.000 description 1
- 102000010168 Myeloid Differentiation Factor 88 Human genes 0.000 description 1
- 101800001020 Non-structural protein 4A Proteins 0.000 description 1
- 101710188652 Non-structural protein 4a Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- MZBLZLWXUBZHSL-FZNJKFJKSA-N O=C([C@H]1N2C[C@H](OC3=NC4=CC(OC)=CC=C4N=C3C(F)(F)CCCC[C@@H]3C[C@H]3OC(=O)N[C@H](C2=O)C(C)(C)C)[C@H]1CC)N[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C(F)F Chemical compound O=C([C@H]1N2C[C@H](OC3=NC4=CC(OC)=CC=C4N=C3C(F)(F)CCCC[C@@H]3C[C@H]3OC(=O)N[C@H](C2=O)C(C)(C)C)[C@H]1CC)N[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C(F)F MZBLZLWXUBZHSL-FZNJKFJKSA-N 0.000 description 1
- 108700005126 Ornithine decarboxylases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100036691 Proliferating cell nuclear antigen Human genes 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 1
- 108091007047 SCF complex Proteins 0.000 description 1
- 102000036366 SCF complex Human genes 0.000 description 1
- 102100031778 SH2 domain-containing protein 1B Human genes 0.000 description 1
- 101710097986 SH2 domain-containing protein 1B Proteins 0.000 description 1
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 1
- MHFMTUBUVQZIRE-WINRQGAFSA-N Sovaprevir Chemical compound C([C@H](C(=O)N1[C@@H](C[C@H](C1)OC=1C2=CC=C(C=C2N=C(C=1)C=1C=CC=CC=1)OC)C(=O)N[C@]1([C@@H](C1)C=C)C(=O)NS(=O)(=O)C1CC1)C(C)(C)C)C(=O)N1CCCCC1 MHFMTUBUVQZIRE-WINRQGAFSA-N 0.000 description 1
- 102100036422 Speckle-type POZ protein Human genes 0.000 description 1
- 102100037331 Transcription factor E4F1 Human genes 0.000 description 1
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
- 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 1
- 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 1
- 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 1
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
- 108091008605 VEGF receptors Proteins 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000005809 anti-tumor immunity Effects 0.000 description 1
- 229960002118 asunaprevir Drugs 0.000 description 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 229960000517 boceprevir Drugs 0.000 description 1
- LHHCSNFAOIFYRV-DOVBMPENSA-N boceprevir Chemical compound O=C([C@@H]1[C@@H]2[C@@H](C2(C)C)CN1C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C)NC(C(=O)C(N)=O)CC1CCC1 LHHCSNFAOIFYRV-DOVBMPENSA-N 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 229950002891 danoprevir Drugs 0.000 description 1
- ZVTDLPBHTSMEJZ-UPZRXNBOSA-N danoprevir Chemical compound O=C([C@@]12C[C@H]1\C=C/CCCCC[C@H](C(N1C[C@@H](C[C@H]1C(=O)N2)OC(=O)N1CC2=C(F)C=CC=C2C1)=O)NC(=O)OC(C)(C)C)NS(=O)(=O)C1CC1 ZVTDLPBHTSMEJZ-UPZRXNBOSA-N 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 210000004475 gamma-delta t lymphocyte Anatomy 0.000 description 1
- 229950008970 glecaprevir Drugs 0.000 description 1
- MLSQGNCUYAMAHD-ITNVBOSISA-N glecaprevir Chemical compound O=C([C@@H]1C[C@H]2OC3=NC4=CC=CC=C4N=C3C(F)(F)/C=C/CO[C@@H]3CCC[C@H]3OC(=O)N[C@H](C(N1C2)=O)C(C)(C)C)N[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C(F)F MLSQGNCUYAMAHD-ITNVBOSISA-N 0.000 description 1
- 229960002914 grazoprevir Drugs 0.000 description 1
- OBMNJSNZOWALQB-NCQNOWPTSA-N grazoprevir Chemical compound O=C([C@@H]1C[C@@H]2CN1C(=O)[C@@H](NC(=O)O[C@@H]1C[C@H]1CCCCCC1=NC3=CC=C(C=C3N=C1O2)OC)C(C)(C)C)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C OBMNJSNZOWALQB-NCQNOWPTSA-N 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 102000047410 human NFKB1 Human genes 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 210000004964 innate lymphoid cell Anatomy 0.000 description 1
- 230000021633 leukocyte mediated immunity Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000007498 myristoylation Effects 0.000 description 1
- 210000000581 natural killer T-cell Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000026792 palmitoylation Effects 0.000 description 1
- 229960002754 paritaprevir Drugs 0.000 description 1
- UAUIUKWPKRJZJV-MDJGTQRPSA-N paritaprevir Chemical compound C1=NC(C)=CN=C1C(=O)N[C@@H]1C(=O)N2C[C@H](OC=3C4=CC=CC=C4C4=CC=CC=C4N=3)C[C@H]2C(=O)N[C@]2(C(=O)NS(=O)(=O)C3CC3)C[C@@H]2\C=C/CCCCC1 UAUIUKWPKRJZJV-MDJGTQRPSA-N 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 210000003289 regulatory T cell Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229960002091 simeprevir Drugs 0.000 description 1
- JTZZSQYMACOLNN-VDWJNHBNSA-N simeprevir Chemical compound O=C([C@@]12C[C@H]1\C=C/CCCCN(C)C(=O)[C@H]1[C@H](C(N2)=O)C[C@H](C1)OC=1C2=CC=C(C(=C2N=C(C=1)C=1SC=C(N=1)C(C)C)C)OC)NS(=O)(=O)C1CC1 JTZZSQYMACOLNN-VDWJNHBNSA-N 0.000 description 1
- 229950010695 sovaprevir Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229960002935 telaprevir Drugs 0.000 description 1
- 108010017101 telaprevir Proteins 0.000 description 1
- BBAWEDCPNXPBQM-GDEBMMAJSA-N telaprevir Chemical compound N([C@H](C(=O)N[C@H](C(=O)N1C[C@@H]2CCC[C@@H]2[C@H]1C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1)C(C)(C)C)C1CCCCC1)C(=O)C1=CN=CC=N1 BBAWEDCPNXPBQM-GDEBMMAJSA-N 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229950004638 voxilaprevir Drugs 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163211468P | 2021-06-16 | 2021-06-16 | |
| US63/211,468 | 2021-06-16 | ||
| US202263305155P | 2022-01-31 | 2022-01-31 | |
| US63/305,155 | 2022-01-31 | ||
| PCT/US2022/033893 WO2022266396A1 (en) | 2021-06-16 | 2022-06-16 | Armed chimeric receptors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024524922A JP2024524922A (ja) | 2024-07-09 |
| JP2024524922A5 JP2024524922A5 (https=) | 2024-08-06 |
| JPWO2022266396A5 true JPWO2022266396A5 (https=) | 2024-08-06 |
Family
ID=84526773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577531A Pending JP2024524922A (ja) | 2021-06-16 | 2022-06-16 | 武装化キメラ受容体及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240277766A1 (https=) |
| EP (1) | EP4355341A4 (https=) |
| JP (1) | JP2024524922A (https=) |
| KR (1) | KR20240022575A (https=) |
| AU (1) | AU2022294896A1 (https=) |
| CA (1) | CA3221897A1 (https=) |
| IL (1) | IL309161A (https=) |
| TW (1) | TW202317753A (https=) |
| WO (1) | WO2022266396A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12264189B2 (en) | 2018-10-31 | 2025-04-01 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| WO2020092736A1 (en) | 2018-10-31 | 2020-05-07 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| WO2024102943A1 (en) * | 2022-11-09 | 2024-05-16 | Senti Biosciences, Inc. | Armed chimeric receptors and methods of use thereof |
| EP4619420A1 (en) * | 2022-11-16 | 2025-09-24 | Regeneron Pharmaceuticals, Inc. | Chimeric proteins comprising membrane bound il-12 with protease cleavable linkers |
| WO2025106924A1 (en) * | 2023-11-16 | 2025-05-22 | Senti Biosciences, Inc. | Methods of enhancing engineered immune cell cytotoxicity |
| WO2025179221A1 (en) * | 2024-02-22 | 2025-08-28 | Senti Biosciences, Inc. | Compositions and methods for armored cell based therapies |
| WO2026077446A1 (en) * | 2024-10-12 | 2026-04-16 | Nanjing Legend Biotech Co., Ltd. | Engineered il-15 constructs and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2794196A1 (en) * | 2010-03-23 | 2011-09-29 | Intrexon Corporation | Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof |
| KR20190102259A (ko) * | 2017-01-10 | 2019-09-03 | 인트렉손 코포레이션 | 신규의 유전자 스위치 발현 시스템을 통한 폴리펩티드의 발현 조절 |
| KR20200056980A (ko) * | 2017-07-12 | 2020-05-25 | 레퓨즈 바이오테크놀로지스, 인크. | 유전자 발현의 조건부 조절을 위한 방법 및 시스템 |
| EP3784256A4 (en) * | 2018-04-27 | 2022-06-29 | Baylor College of Medicine | Car t cells with one or more interleukins |
| TWI809130B (zh) * | 2018-06-22 | 2023-07-21 | 美商凱特製藥公司 | 嵌合跨膜蛋白及其用途 |
| SG11202103317XA (en) * | 2018-10-17 | 2021-05-28 | Senti Biosciences Inc | Combinatorial cancer immunotherapy |
| JP2022512450A (ja) * | 2018-12-13 | 2022-02-03 | カースゲン セラピューティクス カンパニー リミテッド | Ｇｐｃ３を標的とする免疫エフェクター細胞およびその応用 |
| CA3138576A1 (en) * | 2019-05-16 | 2020-11-19 | Trustees Of Boston University | Regulated synthetic gene expression systems |
| US20220396609A1 (en) * | 2019-11-01 | 2022-12-15 | Senti Biosciences, Inc. | Chimeric receptor sensors |
| WO2021119539A1 (en) * | 2019-12-12 | 2021-06-17 | Senti Biosciences, Inc. | Method and compositions for regulated armoring of cells |
| IL302568A (en) * | 2020-11-04 | 2023-07-01 | Senti Biosciences Inc | Protein payload release |
-
2022
- 2022-06-16 KR KR1020247001340A patent/KR20240022575A/ko active Pending
- 2022-06-16 WO PCT/US2022/033893 patent/WO2022266396A1/en not_active Ceased
- 2022-06-16 IL IL309161A patent/IL309161A/en unknown
- 2022-06-16 AU AU2022294896A patent/AU2022294896A1/en active Pending
- 2022-06-16 EP EP22825875.2A patent/EP4355341A4/en not_active Withdrawn
- 2022-06-16 CA CA3221897A patent/CA3221897A1/en active Pending
- 2022-06-16 JP JP2023577531A patent/JP2024524922A/ja active Pending
- 2022-06-16 TW TW111122516A patent/TW202317753A/zh unknown
-
2023
- 2023-12-15 US US18/541,684 patent/US20240277766A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12410248B2 (en) | Chimeric antigen receptor and its use | |
| KR102483755B1 (ko) | 키메라 폴리펩티드 및 그의 용도 | |
| CN113260368B (zh) | 抗gpc3嵌合抗原受体(car)与反式共刺激分子的组合及其治疗用途 | |
| KR102619015B1 (ko) | 면역 반응을 조절하는 방법 | |
| AU2016336866B2 (en) | Multivalent Fv antibodies | |
| EP3472205B1 (en) | Chimeric antigen receptor | |
| US12059436B2 (en) | BCMA-CAR-T cells | |
| CN110352245A (zh) | 可分泌变体免疫调节蛋白和工程化细胞疗法 | |
| WO2020163646A1 (en) | Anti-gitr antigen-binding domains and uses thereof | |
| JP2018529363A5 (https=) | ||
| CN110291111A (zh) | 重组pMHC II类分子 | |
| KR20180054713A (ko) | 조율가능한 변종 면역글로불린 수퍼패밀리 도메인 및 유전자 조작된 세포 치료법 | |
| CN115836087A (zh) | 抗cd26蛋白及其用途 | |
| KR20220025698A (ko) | 다기능 융합 단백질 및 이의 용도 | |
| WO2019118518A2 (en) | Inducible cell receptors for cell-based therapeutics | |
| CN113045657B (zh) | 一种人源化抗人bcma单克隆抗体及其car-t细胞 | |
| CN120051292A (zh) | Il-18融合蛋白以及生产il-18的方法 | |
| KR20190133734A (ko) | 키메라 폴리펩티드 및 그의 세포 막 내 국재화를 변경시키는 방법 | |
| EP4107175A1 (en) | Inhibitory chimeric receptor architectures | |
| CN121532203A (zh) | Il-18融合蛋白的使用方法 | |
| JPWO2021119539A5 (https=) | ||
| JPWO2022266396A5 (https=) | ||
| US12528873B2 (en) | Humanized BCMA antibody and BCMA-CAR-T cells | |
| KR20230061486A (ko) | 면역 세포 내 어댑터의 유도성 발현을 위한 시스템 | |
| US20250115657A1 (en) | Bispecific FC Fusion Proteins with sPD-1 and IL-15 |